Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
SWX:NOVN
Novartis
|
88.87 | 13,62% | 27,66% | 181.330,92 | 3,71% | 4,67% |
|
SWX:ROG
Roche Holding
|
214.10 | 38,81% | 55,75% | 172.833,99 | 4,35% | 0,43% |
|
NYSE:A
Agilent Technologies
|
137.52 | 15,02% | 27,96% | 40.300,96 | 0,68% | 14,29% |
|
NasdaqGS:ILMN
Illumina
|
123.99 | 0% | 0% | 19.746,08 | 0% | -34,68% |
|
NasdaqGS:HOLX
Hologic
|
75.91 | -21,22% | -14,58% | 17.818,47 | 0% | 12,17% |
|
NYSE:LH
Laboratory Corp of America Holdings
|
200.25 | -6,59% | 3,42% | 16.879,8 | 1,43% | 4,24% |
|
NYSE:DGX
Quest Diagnostics
|
136.34 | -5,51% | 3,66% | 15.146,23 | 2,18% | 6,66% |
|
ENXTPA:ERF
Eurofins Scientific
|
56.50 | 13,37% | 28,53% | 11.108,45 | 0,87% | 7,46% |
|
NasdaqGS:NTRA
Natera
|
93.72 | 0% | 0% | 11.353,8 | 0% | 0% |
|
NYSE:QGEN
QIAGEN N.V.
|
42.68 | 9,06% | 19,76% | 9.390,78 | 0% | 9,09% |
|
ASX:SHL
Sonic Healthcare
|
25.94 | 6,14% | 28,79% | 12.860,41 | 3,95% | 5,68% |
|
NYSE:BIO
Bio-Rad Laboratories Inc
|
279.31 | 87,47% | 117,13% | 7.744,62 | 0% | 15,07% |
|
NasdaqGS:TXG
10x Genomics
|
26.29 | 0% | 0% | 3.505,06 | 0% | 0% |
|
NasdaqGS:GH
Guardant Health
|
18.58 | 0% | 0% | 2.193,93 | 0% | 0% |
|
NasdaqGS:SDGR
Schrödinger
|
23.19 | 0% | 0% | 1.835,88 | 0% | 0% |
|
NasdaqGS:TWST
Twist Bioscience
|
32.01 | 0% | 0% | 1.850,75 | 0% | 0% |
|
NasdaqCM:NEO
NeoGenomics
|
14.72 | -.134,82% | -54,64% | 1.777,11 | 0% | 0% |
|
NasdaqGS:MYGN
Myriad Genetics
|
19.22 | -.100,22% | -86,54% | 1.770,66 | 0% | 0% |
|
NasdaqGM:VCYT
Veracyte
|
20.19 | 0% | 0% | 1.496,08 | 0% | 0% |
|
NasdaqGS:OPK
OPKO Health
|
1.01 | 0% | 0% | 1.182,78 | 0% | -.200% |
